GoodRx Holdings, Inc.GDRXNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-21.5%
5Y CAGR-43.0%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-21.5%/yr
vs -56.8%/yr prior
5Y CAGR
-43.0%/yr
Recent acceleration
Acceleration
+35.3pp
Accelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
20251.21-46.5%
20242.26-38.2%
20233.66+46.0%
20222.51-86.0%
202117.97-10.7%
202020.12-56.6%
201946.32-35.7%
201872.06-41.8%
2017123.77-36.8%
2016195.84-